Cargando…

Relative Incidence of Acute Adverse Events with Ferumoxytol Compared to Other Intravenous Iron Compounds: A Matched Cohort Study

Concerns persist about adverse reactions to intravenous (IV) iron. We aimed to determine the relative safety of ferumoxytol compared to other IV iron compounds. This retrospective cohort study with propensity-score matching for patients and drug doses used the Medicare 20% random sample to identify...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wetmore, James B., Weinhandl, Eric D., Zhou, Jincheng, Gilbertson, David T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279762/ https://www.ncbi.nlm.nih.gov/pubmed/28135334 http://dx.doi.org/10.1371/journal.pone.0171098

Ejemplares similares

Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial
por: Adkinson, N. Franklin, et al.
Publicado: (2018)

Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy
por: Gerb, Jesse, et al.
Publicado: (2021)

COVID-19−Associated Decline in the Size of the End-Stage Kidney Disease Population in the United States
por: Weinhandl, Eric D., et al.
Publicado: (2021)

Anaphylaxis with elevated serum tryptase after administration of intravenous ferumoxytol
por: Santosh, Sadashiv, et al.
Publicado: (2010)

Relative Survival With Peritoneal Dialysis: The Hunt for a Comparator Continues
por: Weinhandl, Eric D., et al.
Publicado: (2020)

Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer
por: Vadhan-Raj, Saroj, et al.
Publicado: (2017)

The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2017)

Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2018)

Oxidation of ferumoxytol by ionizing radiation releases iron. An electron paramagnetic resonance study
por: Petronek, Michael S, et al.
Publicado: (2022)

Imaging Tumor Necrosis with Ferumoxytol
por: Aghighi, Maryam, et al.
Publicado: (2015)

Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA
por: Dahl, Naomi V, et al.
Publicado: (2017)

Ferumoxytol-enhanced MR imaging for differentiating intrapancreatic splenules from other tumors
por: Muehler, M. R., et al.
Publicado: (2020)

Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
por: Macdougall, Iain C., et al.
Publicado: (2019)

Brain iron deposition after Ferumoxytol-enhanced MRI: A study of Porcine Brains
por: Theruvath, Ashok Joseph, et al.
Publicado: (2020)

Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron
por: Vadhan-Raj, Saroj, et al.
Publicado: (2014)

Head and neck vessel magnetic resonance angiography appearance and artifacts after therapeutic intravenous ferumoxytol infusion
por: Hanreck, James Cody, et al.
Publicado: (2023)

Association of the End-Stage Renal Disease Treatment Choices Payment Model With Home Dialysis Use at Kidney Failure Onset From 2016 to 2022
por: Johansen, Kirsten L., et al.
Publicado: (2023)

Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions
por: Adkinson, N Franklin, et al.
Publicado: (2017)

A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy
por: Hetzel, David, et al.
Publicado: (2014)

The ferumoxytol in renal insufficiency study (FiRST)
por: Vemulapalli, Sreekanth, et al.
Publicado: (2013)

Ferumoxytol MR angiography for pre-TAVR assessment
por: Finn, J Paul, et al.
Publicado: (2016)

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders
por: Ford, David C, et al.
Publicado: (2016)

Analysis of Adverse Events and Intravenous Iron Infusion Formulations in Adults With and Without Prior Infusion Reactions
por: Arastu, Asad H., et al.
Publicado: (2022)

Acute effects of ferumoxytol on regulation of renal hemodynamics and oxygenation
por: Cantow, Kathleen, et al.
Publicado: (2016)

Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis
por: Stirrat, Colin G, et al.
Publicado: (2018)

Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation
por: Stirrat, Colin G, et al.
Publicado: (2019)

Incidence of Iron Deficiency and the Role of Intravenous Iron Use in Perioperative Periods
por: Țigliș, Mirela, et al.
Publicado: (2020)

Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia
por: Strauss, William E., et al.
Publicado: (2016)

Measurement of myocardial blood volume and water exchange using ferumoxytol
por: Chatterjee, Neil, et al.
Publicado: (2015)

Measurement of myocardial blood volume and water exchange using ferumoxytol
por: Chatterjee, Neil, et al.
Publicado: (2015)

Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging
por: Nguyen, Kim-Lien, et al.
Publicado: (2017)

The Emerging Role of Ferumoxytol-Enhanced MRI in the Management of Cerebrovascular Lesions
por: Chalouhi, Nohra, et al.
Publicado: (2013)

Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle
por: Huang, Yue, et al.
Publicado: (2022)

Vascular mapping of the human hippocampus using Ferumoxytol-enhanced MRI
por: Buch, Sagar, et al.
Publicado: (2022)

1–2 T static magnetic field combined with Ferumoxytol prevent unloading-induced bone loss by regulating iron metabolism in osteoclastogenesis
por: Zhang, Gejing, et al.
Publicado: (2022)

Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System
por: Trumbo, Henry, et al.
Publicado: (2020)

Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: A retrospective analysis
por: Foley, Robert N, et al.
Publicado: (2008)

Ferumoxytol across the age spectrum: a single center experience of safety
por: Nguyen, Kim-Lien, et al.
Publicado: (2016)

Ferumoxytol Attenuates the Function of MDSCs to Ameliorate LPS-Induced Immunosuppression in Sepsis
por: Xue, Yaxian, et al.
Publicado: (2019)

Ferumoxytol-enhanced MR venography for diagnosis of venous thoracic outlet syndrome
por: Lan, Christopher, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jp6nbv6grhp0n5pht7ta1mf5cf